Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Traveling Alone: An Excursion of Self-Disclosure - 2Hilary Duff releases 'Mature,' her 1st song in 10 years
- 3Cruising Solo All over the Planet: An Excursion of Self-Disclosure
- 4Director of Swiss hospital describes the rush to treat the injured from Alpine resort bar fire
- 5Intriguing Strange Cruising Objections you Should Visit
- Top Music and Dance Celebration: Which One Gets You Going?
- How one man's concern saved his brothers from heart disease
- Opening Monetary Information: Your Exhaustive Manual for Finding out about Individual budget
- Step by step instructions to Pick the Ideal Authorize Internet Advertising Degree Program
- I binged all 24 Hallmark Christmas movies in less than 30 days. I emerged a changed man.
- Optimal Beauty Parlor Medicines for Upgraded Wellbeing and Appearance
- 'Crammed into a cell with vermin at New Year'
- Indian rocket launches record-breaking BlueBird 6 smartphone satellite to orbit (video)
- Hamas Navy head, engineer of Khan Yunis tunnel network killed in Gaza, IDF confirms
